http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2360819-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c63d50887bc455a4a35d4ec59ed51d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c2dd7e5ea14a6711beb2280ff75cf4 |
| publicationDate | 2011-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2360819-T3 |
| titleOfInvention | PROCEDURE FOR THE PREPARATION OF AN ANTAGONIST OF THE ANGIOTENSIN II RECEIVER. |
| abstract | A process for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof in which: G is H or a tetrazole protecting group, which comprises the reaction between an intermediate of formula (II) or an addition salt of acid thereof in which: R 1 is a tetrazolyl group or an intermediate or protected form that can be transformed into a tetrazolyl group and an intermediate of formula (III) into an appropriate solvent system and then when necessary to transform said intermediate or protected forms of R 1 in a tetrazolyl group and, if desired, converting said compound of formula (I) into a pharmaceutically acceptable salt thereof. |
| priorityDate | 2005-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.